SLDB stockholders approve doubling authorized shares to 240M and adding 9M shares to equity plan

Solid Biosciences Inc.

Authorized common stock increased from 120M to 240M via Certificate of Amendment filed June 12, 2025.
Equity plan amended to add 9M shares and modify evergreen provision to 6% annual increase from 2026.
Class I directors Alexander Cumbo and Sukumar Nagendran re-elected with 95% and 92% of votes cast, respectively.
PricewaterhouseCoopers ratified as auditor for FY2025 with 68.9M votes for, 18.8K against.
Say-on-pay advisory vote approved with 57.1M for vs. 5.1M against; 6.6M broker non-votes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.